Fndc5/irisin-enriched extracellular vesicles: a new hormonal relay in the regular race against vascular ageing

Vincenzo Lionetti¹, Lucio Barile^{2

3}

Affiliations

¹ Unit of Translational Critical Care Medicine, Scuola Superiore Sant'Anna, Pisa, Italy.
² Cardiovascular Theranostics, Istituto Cardiocentro Ticino, Laboratories for Translational Research, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.
³ Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland.

Editorial

Vincenzo Lionetti et al. Eur Heart J. 2022.

. 2022 Nov 14;43(43):4596-4598.

doi: 10.1093/eurheartj/ehac517.

Vincenzo Lionetti¹, Lucio Barile^{2

3}

¹ Unit of Translational Critical Care Medicine, Scuola Superiore Sant'Anna, Pisa, Italy.
² Cardiovascular Theranostics, Istituto Cardiocentro Ticino, Laboratories for Translational Research, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.
³ Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland.

No abstract available

Conflict of interest statement

Conflict of interest: None declared.

Exerkine fibronectin type-III domain-containing protein 5/irisin-enriched extracellular vesicles delay vascular ageing by increasing SIRT6 stability.
Chi C, Fu H, Li YH, Zhang GY, Zeng FY, Ji QX, Shen QR, Wang XJ, Li ZC, Zhou CC, Sun DY, Fu JT, Wu WB, Zhang PP, Zhang JB, Liu J, Shen FM, Li DJ, Wang P. Chi C, et al. Eur Heart J. 2022 Nov 14;43(43):4579-4595. doi: 10.1093/eurheartj/ehac431. Eur Heart J. 2022. PMID: 35929617